Circulating tumor DNA: toward evolving the clinical paradigm of pancreatic ductal adenocarcinoma. | Ther Adv Med Oncol;15: 17588359231157651, 2023. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Circulating tumor DNA: toward evolving the clinical paradigm of pancreatic ductal adenocarcinoma.

Topham, James T; Renouf, Daniel J; Schaeffer, David F.

Affiliation

Topham JT; Pancreas Centre BC, Vancouver, BC, Canada.
Renouf DJ; Pancreas Centre BC, Vancouver, BC, Canada.
Schaeffer DF; Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada.

Ther Adv Med Oncol ; 15: 17588359231157651, 2023.

Article in En | MEDLINE | ID: mdl-36895849

Key words

KRAS mutation; circulating tumor DNA; genetic testing; liquid biopsy; molecular testing; pancreatic cancer

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Ther Adv Med Oncol Year: 2023 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Ther Adv Med Oncol Year: 2023 Document type: Article Affiliation country: Country of publication: